Varince Pharma Private Limited

Varince Pharma Private Limited - pharma in Tuticorin, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U74900TN2013PTC093071 Incorporated 20 September 2013 ROC Chennai HQ Tuticorin, Tamil Nadu, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹67.22 Lakh
▲ 66% YoY
Net profit · FY 2025
₹2.85 Lakh
Net margin 4.2%
EBITDA · FY 2025
₹3.85 Lakh
EBITDA margin 5.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Varince Pharma Private Limited

Data last updated:

Varince Pharma Private Limited is a private limited company based in Tuticorin, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 September 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2013PTC093071. Its GSTIN is 33AAECV5824G1ZE (Tamil Nadu).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shenbagam Muthumanickam Renuka (Managing Director) and Chinnadurai Prince Soyus.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4/149 Statebank Colony, Tuticorin, Tamil Nadu, India – 628002.

As per the financials filed for FY 2025, the company reported a revenue of ₹67.22 Lakh, a growth of 66% compared to the previous year. For the same year it recorded a net profit of ₹2.85 Lakh (net margin 4.2%) and EBITDA of ₹3.85 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 10% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Varince Pharma Private Limited
CIN U74900TN2013PTC093071
Registration Number 093071
Incorporation Date 20 September 2013
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    4/149 Statebank Colony, Tuticorin, Tamil Nadu, India – 628002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Varince Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Varince Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Varince Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Varince Pharma Private Limited

The main business activity of Varince Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Varince Pharma Private Limited FY 2025 filings available

Varince Pharma Private Limited reported revenue of ₹67.22 Lakh (up 66% YoY) for FY 2025.

Revenue · FY 2025
₹67.22 Lakh ▲ 66%
Net profit · FY 2025
₹2.85 Lakh margin 4.2%
EBITDA · FY 2025
₹3.85 Lakh margin 5.7%

Compounded Annual Growth Rate (CAGR) of Varince Pharma Private Limited

Revenue CAGR growth
1 year
▲ 66%
3 years · compounded
▲ 20%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 36%
5 years · compounded
▲ 9%

Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 66% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Varince Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹3.85 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹2.85 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Varince Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.7%••••••••••••••••
Net Profit Margin4.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Varince Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Varince Pharma Private Limited

Varince Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Chinnadurai Prince SoyusDirector20 Sep 201313 Years 1 MonthsCurrent
Shenbagam Muthumanickam RenukaManaging Director20 Sep 201313 Years 1 MonthsCurrent

Peer Comparison of Varince Pharma Private Limited

Varince Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Movani Pharma Private Limited₹67.71 Lakh (FY 2023)••••••••530.0%••••Mumbai, Maharashtra, India
Youth Energy Health Marketing Private Limited₹67.58 Lakh (FY 2024)••••••••-68.0%••••Bijnor, Uttar Pradesh, India
Waxemon Pharmaceuticals (OPC) Private Limited₹67.52 Lakh (FY 2025)••••••••2.0%••••Lucknow, Uttar Pradesh, India
Seramic Pharmaceuticals Private Limited₹67.42 Lakh (FY 2025)••••••••-49.0%••••Bhiwandi, Maharashtra, India
Lifewins Medicare Private Limited₹67.24 Lakh (FY 2022)••••••••0.0%••••Navi Mumbai, Maharashtra, India
Varince Pharma Private Limited this company₹67.22 Lakh (FY 2025)••••••••66.0%••••Tuticorin, Tamil Nadu, India
Wellness First Global Koncepts Private Limited₹67.21 Lakh (FY 2025)••••••••-66.0%••••New Delhi, Delhi, India
Amrut Manthan Tradelink Private Limited₹67.19 Lakh (FY 2024)••••••••-20.0%••••Rajkot, Gujarat, India
Kalash Metals Private Limited₹67.17 Lakh (FY 2025)••••••••-9.0%••••Mumbai, Maharashtra, India
Biocase Foods and Extracts Private Limited₹66.93 Lakh (FY 2024)••••••••••••Hisar, Haryana, India
Lemurik Healthcare Private Limited₹66.9 Lakh (FY 2020)••••••••-18.0%••••Bangalore, Karnataka, India

Peers are the five companies nearest above and the five nearest below Varince Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Varince Pharma Private Limited

Varince Pharma Private Limited is audited by ABUSALI SIDDIQUE & ASSOCIATES for the financial year 2019.

NameStatusAppointment DateCessation Date
ABUSALI SIDDIQUE & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Varince Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Varince Pharma Private Limited

Varince Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Varince Pharma Private Limited

Employment history and EPFO contributions of people linked to Varince Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Varince Pharma Private Limited

Varince Pharma Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Gomathinayagam Mariappan Venkatesh ceased to be Director on 02 Apr 2019.

AGM
Varince Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Varince Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Gomathinayagam Mariappan Venkatesh ceased to be Director.
Ceased
Madaswamy Subbulakshmi ceased to be Director.
Appointed
Chinnadurai Prince Soyus was appointed as Director.
Appointed
Shenbagam Muthumanickam Renuka was appointed as Managing Director.
Incorporation
20 Sep 2013
Varince Pharma Private Limited was registered on 20 Sep 2013 with Roc Chennai & aged 13 years 1 month as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Varince Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Varince Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Varince Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Varince Pharma Private Limited

Varince Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAECV5824G1ZETamil NaduActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Varince Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Varince Pharma Private Limited

Varince Pharma is an active private limited company based in Tuticorin, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 September 2013 (13+ years old) and is registered under CIN U74900TN2013PTC093071.

Varince Pharma reported revenue of ₹67.22 Lakh for FY 2025 (up 66% YoY).

Varince Pharma has 2 current directors:

Varince Pharma reported a net profit of ₹2.85 Lakh (net margin 4.2%) and EBITDA of ₹3.85 Lakh (EBITDA margin 5.7%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Varince Pharma is 20% over three years and 10% over five years. In the latest year (FY 2025) revenue rose 66%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Varince Pharma is 33AAECV5824G1ZE, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Varince Pharma is U74900TN2013PTC093071. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Varince Pharma was incorporated on 20 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Varince Pharma by revenue are Movani Pharma Private Limited, Youth Energy Health Marketing Private Limited, Waxemon Pharmaceuticals (OPC) Private Limited, Seramic Pharmaceuticals Private Limited, Lifewins Medicare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Gomathinayagam Mariappan Venkatesh ceased to be Director on 02 Apr 2019. Madaswamy Subbulakshmi ceased to be Director on 02 Apr 2019. Chinnadurai Prince Soyus was appointed as Director on 20 Sep 2013. Varince Pharma has 4 board changes on record in total.

The registered office of Varince Pharma is at 4149 Statebank Colony, Tuticorin, Tamil Nadu, India – 628002.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available